1.Alternative Name:IL-1RAcP,C3orf13,IL1R3
2.Target:IL1RAP
3.Source:Human IL1RAP was expressed from HEK293 with human IgG1 FC at the C-terminal
4.Sequence:Glu22-Glu359
5.Protein structure:Q9NPH3hFC
6.Molecular Characterization:The protein has a calculated MW of 65kDa.The reducing (R) heterodimer protein migrates as 70-100 kDa due to glycosylation
7.Purity:SDS-PAGE>90%，SEC>95%
8.Reconstitution:sterile H2O
9.Endotoxin:<1EU/mg
10.Formulation:Lyophilized from 0.22 μm filtered solution in PBS, pH7.4.
Note:For research use only .


11.SDS-PAGE

Determined by SDS-PAGE, the purity of the protein is greater than 90%.

12.SEC-HPLC

Determined by SEC-HPLC, the purity of the protein is greater than 95%.

13.ELISA

When Recombinant Human IL1RAP/hFC Protein is immobilized at 2μg/mL (100 μL/well), the concentration of Anti-Human IL1RAP(Nadunolimab) that produces 50% of the optimal binding response is approximately 0.1ug/ml.